Skip to content

Assessment of an Innovative Air Mattress on Critically Ill Infants

Assessment of an Innovative Air Mattress on Critically Ill Infants

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06425068
Acronym
Prepicare
Enrollment
23
Registered
2024-05-22
Start date
2024-05-07
Completion date
2024-09-10
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Abnormalities, Skin; Injury, Superficial, Skin; Ulcer, Decubitus

Keywords

Air mattress, Skin interface pressure, Skin contact area, Lying comfort

Brief summary

The permanent bedding of critically ill neonates and infants in the pediatric intensive care unit (PICU) for an extended amount of time can result in the development of pressure injuries (PI). PIs can form due to high and permanent local interface pressure induced by contact with bed surfaces or other medical devices. The currently used state-of-the-art support systems consist of conventional foam mattresses. In this study, the investigators explore the effect of a newly developed air mattress with regard to contact are and reduction in the average interface pressure in infants assigned to the pediatric intensive care unit of the childrens hospital in Zurich.

Detailed description

The permanent bedding of critically ill neonates and infants in the pediatric intensive care unit (PICU) for an extended amount of time can result in the development of pressure injuries (PI). This results in a further prolongation of the hospital stay, additional suffering of the patient, scarring, increased mortality and morbidity, and increased healthcare costs. Infants are at particular risk since their skin hasn't matured yet and is mechanically weak, and for example neonates lack a robust stratum corneum entirely. Furthermore, the thickness of their skin is reduced by 60% when compared to skin of adults. Thus, pressure cannot be equally absorbed leading to higher tissue internal stress. PIs can form due to high and permanent local interface pressure induced by contact with bed surfaces or other medical devices. Contact pressure can hamper blood flow in subcutaneous areas, increasing susceptibility for pressure injuries. While sophisticated equipment to manage the interface pressure and reduce the risk of developing pressure injuries is abundant for adults, very little is designed explicitly for neonates and infants. The currently available air mattresses are not being used due to safety concerns and impracticability. Furthermore, they are designed for infants from half a year of age and, thus, not considering the low body weight of premature babies or neonates. This is why the currently used conventional foam mattresses remain first choice. However, foam mattresses are designed for optimal support of a specific weight and, therefore, making them unsuitable for the use as a one-fits-all solution in a highly heterogenic patient cohort. In addition, compressed foam gets stiffer at compressed areas, increasing the local pressure impact and, thus, PI risk. On the other hand, the structures of the hereby-developed air mattress can freely move and optimally adjust to the patient's body shape. This increases contact area, reduces the average interface pressure and blunts local pressure peaks at the areas with the most indentation, ensuring a more homogenous pressure distribution at a lower level. This ultimately is expected to result in a lower PI incidence. As a side effect, lying comfort for the patient will be increased.

Interventions

DEVICEExposure of the patient to a novel air mattress.

see information provided in the Arms section (experimental)

DEVICEExposure of the patient to a conventional foam mattress.

see information provided in the Arms section (active comparator)

Sponsors

University Children's Hospital, Zurich
CollaboratorOTHER
Simon Annaheim
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

The study population comprises 26 patients being exposed to the conventional foam mattress (active comparator) and the novel air mattress (experimental) for one hour each in a random order. Interface pressure and contact are will be measured by means of a pressure mattress applied on top of the support systems. The patient comfort will be assessed objectively based on vital sign readings and subjectively based on questionnaire filled by professional care personnel and parents.

Eligibility

Sex/Gender
ALL
Age
10 Days to 6 Months
Healthy volunteers
No

Inclusion criteria

* Informed consent signed by the legal guardian * Admitted to the pediatric intensive care unit (PICU) * Age: late preterm (\>34 gestational age) up to 6 months * Admission at least 24 hours to PICU prior to intervention * Presence/availability of at least one parent/legal guardian

Exclusion criteria

* Life threatening condition * Patients who cannot be positioned in supine position * Skin injury at body area in contact with support surface * Patients with congenital skin disorders * Patients with omphalocele or gastroschisis * Newborns with peripartum asphyxia and hypothermia therapy * Language communication difficulties with the legal guardians * Surgical patients on the day of surgery * birth weight \<1250g

Design outcomes

Primary

MeasureTime frameDescription
Interface pressure resulting from the exposure of patients to the supportive structures as measured by a pressure sensitive mat (xsensor, LX100:100.160.05, XSENSOR Technology Corporation, Calgary, Canada).baselineQuantification of interface pressure between the patient and the mattress surfaces with emphasis on data of highest pressures (median for top 25% of pressure data observed; 4th quartile of pressure data).

Secondary

MeasureTime frameDescription
Difference in stress assessment by means of heart ratebaselineMeasurement of heart rate obtained from clinical routine patient surveillance.
Stress assessment by means of heart rateafter 60 minutes of exposure to the mattressMeasurement of heart rate obtained from clinical routine patient surveillance.
Stress assessment by means of respiratory ratebaselineMeasurement of respiratory rate obtained from clinical routine patient surveillance.
Stress assessment by means of blood pressure (mean arterial pressure)baselineMeasurement of blood pressure obtained from clinical routine patient surveillance.
Stress assessment by means of blood oxygen saturationbaselineMeasurement of blood oxygen saturation obtained from clinical routine patient surveillance.
Stress assessment by means of body temperaturebaselineMeasurement of body temperature obtained from clinical routine patient surveillance.
Comfort assessment by means of a visual analogue scalebaselineQuantification of comfort level ranging from 0 \[very uncomfortable\] to 10 \[very comfortable\].
Contact area resulting from the exposure of patients to the supportive structures as detected by a pressure sensitive mat (xsensor, LX100:100.160.05, XSENSOR Technology Corporation, Calgary, Canada)baselineQuantification of contact are between the patient and the mattress surface.
Pain assessment by means of the questionnaire Bern pain score for newborns - Revised (BSN-R)baselineAssessment of pain indicators (crying, facial expression, body tension, heart rate) ranging from 0 points (no pain indication) to 3 points (high pain indication). Total values \>5 points for premature babies and \>3 points for term babies is indicative for pain.
Unrest assessment by means of the Richmond Agitation-Sedation Scale (RASS) questionnairebaselineValues range from -1 (sleepy) to 0 (attentive and calm) to +4 (belligerent).
Skin perfusion assessment by means of capillary refill timebaselineAssessment of the capillary refill time according to Jevon and Gallier (2020).
Skin assessment according to standard clinical procedurebaselineIdentification and localisation (nose, mouth, occipital, face, ear, back, leg, foot, heel, others) of skin irregularities and evaluation of severity of irregularity (redness, partial injury of skin layers, all skin layers affected, complete tissue loss) according to clinical routine
Skin assessment by means of questionnaireafter 60 minutes of exposure to the mattressIdentification and localisation (nose, mouth, occipital, face, ear, back, leg, foot, heel, others) of skin irregularities and evaluation of severity of irregularity (redness, partial injury of skin layers, all skin layers affected, complete tissue loss) according to clinical routine
Delirium assessment by means of the Cornell Assessment of Pediatric Delirium score (CAPD)baselineAssessment of delirium indicators (eye contact, purposeful actions, awareness of surroundings, communication of needs, restlessness, refusal to be comforted, hypoactivity, response time) ranging from 0 points (not indicative for delirium) to 4 points (highly indicative for delirium). A delirium state is considered from a total value of \>8 points.
Withdrawal assessment by means of the Sophia Observation Withdrawal Symptoms scale (SOS)baselineAssessment of withdrawal indicators (autonomic dysfunction \[4 aspects\], overstimulation of the central nervous system \[9 aspects\], dysfunction of the gastrointestinal tract \[2 aspects\] ranging from 0 points (not detectable) to 1 point (detectable). A withdrawal state is considered from a total value of \>3 points.
Stress assessment by means of a visual analogue scalebaselineQuantification of stress level ranging from 0 \[totally relaxed\] to 10 \[very stressed\].

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026